Sherif S. Farag

BTCRC-AML18-342

Phase I trial of azacitidine plus nivolumab following reduced-intensity allogeneic PBSC transplantation for patients with AML and high-risk myelodysplasia. Big Ten Cancer Research Consortium BTCRC-AML18-342
Status
Closed
Cancer Types
Leukemia
Locations

MM08-141

A Phase I/II Trial of Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed or Refractory Multiple Myeloma: Hoosier Cancer Research Network MM08-141
Status
Closed
Cancer Types
Mutiple Myeloma
Locations